This paper addresses The 3 Steps of Developing a CCS: Assessment, Acceptance, and Remediation.
1. Assessment: Outline the CCS
2. Acceptance: Compilation of CCS Documentation
3. Remediation: CCS Evaluation
Annex 1 2008 is the basis for the 2022 version. This paper provides an easy-to-understand side by side comparison of the Annex 1 2008 v. 2022 versions, broken down by section.
The primary importance of environmental monitoring for Advanced Therapeutic Medicinal Products (ATMP) facilities is to demonstrate the highest degree of control over
* The aseptic manufacturing environment
* The potential for cross contamination between batches / manipulations
With the inclusion of cleanroom validation and qualification in the flexible and scientifically sound pharmaceutical processes proposed by the new Annex 1 revision, an overall review of pharmaceutical development is essential. The aim of pharmaceutical development is to design a quality product and a manufacturing process to consistently deliver the intended performance of the final product.